CBPO News and Press, China Biologic Products Holdings Inc. From 08/05/19

--2Q19 Total Sales Up 12.7% YoY in USD terms, or 20.4% YoY in RMB terms; Net Income Up 45.5% YoY to $41.6 Million ; Non-GAAP Adjusted Net Income Up 29.1% YoY in RMB terms -- --1H19 Total Sales Up 14.0% YoY in USD terms, or 21.3% YoY in RMB terms; Net Income Up 31.7% YoY to $79....

AEIS , AEL , ANSS , APLE , APU , ATSG , AVID , AWR , AXNX , BHF , BKD , BKH , BWXT , CAR , CBPO , CBT , CDEV , CLR , COHU , CSOD , CXW , CYH , CZR , DEI , DIOD , DOOR , DRH , EVBG , FRPT , FRTA , GPRE , HIIQ , HLIO , HPR , IFF , IPAR , ITRI , IVC , KLA...

BEIJING , July 26, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release its second quarter 2019 fin...

Biotech Pulse The first half of 2019 had a little bit of everything for biotechs. After a punishing close to last year, with the Nasdaq Biotechnology Index ( IBB ) down 10% for 2018, biotechs rebounded during the first quarter along with the broader market. However, the second quarter provid...

China Biologic Products Holdings, Inc. (NASDAQ: CBPO ) provides blood products and operates profitably. However, sales have fallen recently causing uncertainty over the company's future growth prospects. The stock is quite expensive and with the uncertainty, I'm on the sidelines for now. Fi...

Biotech Pulse Biotech shares are up this year, as represented by the Nasdaq Biotechnology Index ( IBB ), which is the industry benchmark, and the S&P Select Biotechnology Index ( XBI ), after a sharp decline in 2018. This is a welcome respite for biotech investors. However, it has not ...

Market Pulse The month of May thus far has been mostly a downward ride with an occasional rise, proving to be a mere bunny bump, as indexes have eroded persistently on the lack of a trade resolution with China, an outcome that at one point was considered to be almost in the bag. This is rais...

Biotech Pulse The Nasdaq Biotech ( IBB ) and the S&P Biotech ( XBI ) indexes have struggled since March as the broader healthcare sector ( XLV ) declined following growing momentum amongst the presidential candidates for a universal healthcare plan. This was at a time when the broader ma...

China Biologic Products Holdings, Inc. (CBPO) Q1 2019 Earnings Conference Call May 13, 2019 07:30 AM ET Company Participants Samuel Martin - Investor Relations Joseph Chow - Chairman Ming Yin - Senior Vice President Conference Call Participants Yolanda Hu - Morgan Stanley ...

China Biologic Products (NASDAQ: CBPO ): Q1 Non-GAAP EPS of $1.11 beats by $0.13 ; GAAP EPS of $0.94 beats by $0.26 . Revenue of $129.8M (+15.4% Y/Y) beats by $10.3M . Press Release More news on: China Biologic Products Holdings, Inc., Earnings news and commentary, Healthcare stoc...